Download presentation
Presentation is loading. Please wait.
Published byAmbrose McDonald Modified over 8 years ago
1
Nikita, Jenna, and Neil Towery
2
We believe that the benefits of gene therapy outweigh the risks and losses far too much for clinical trials to cease any time soon.
3
relatively new idea meaning that certain complications have not been solved yet many do not trust field isolated deaths and cases of leukemia-like cancer developing trials sometimes paused due to setbacks may give false hope other (often unreliable) options available in some cases such as bone marrow transplant
4
warranted action as everyone consents advancement only possible with trials and similar methods diseases being treated (which have few if any treatments available) justify aggressive trials could potentially provide long-term fix for a variety of genetic diseases history of more good cases than bad (7 to 2) some types do not require viruses for gene dispersal
5
trial centered on muscular dystrophy at Stanford University could potentially provide a long-term solution promising early results gene inserted directly into cell’s own DNA allowing permanent correction does not rely on virus and therefore aviods some key issues such as cancer and an immune reaction seem to be no serious side effects
6
trial centered on Leber’s congenital amaurosis allows for gradually improved vision in the nearly blind millions of copies of a working gene injected beneath the retina and into the back of the eye no evidence that altered virus used to ferry gene into eye travelled to other areas of body seem to be no serious side effects
7
Patients (or parents) must be fully briefed on the risks as well as the benefits of gene therapy before consent is given. Gene therapy cannot be used to “create” your perfect child, only as treatment for diseases.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.